* Meta-terms correspond to biological or medical specialty concerned with one or more keywords (or keywords hierarchies), qualifiers, or resource types. Other terms also benefit from this structure, when the topic warrants it, eg education. See the list.

Doc'CISMeF search for this specility :


Preferred Label : pharmacy;

True Meta (CISMeF) : O;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-acces-derogatoire/maribavir
2024
false
false
false
France
French
maribavir
drug information
administration, oral
maribavir
cytomegalovirus infections
adult
Refractory Cytomegalovirus Infection
antiviral agents

---
https://www.has-sante.fr/jcms/p_3443053/fr/enhertu-trastuzumab-deruxtecan-cancer-du-sein-her2
2024
false
false
false
France
adult
treatment outcome
insurance, health, reimbursement
Unresectable HER2-Positive Breast Carcinoma
Metastatic HER2-Positive Breast Carcinoma
neoplasm metastasis
trastuzumab deruxtecan
guidelines for drug use
Antineoplastic Agents, Immunological
infusions, intravenous
evaluation of the transparency committee
breast neoplasms
trastuzumab deruxtecan
Trastuzumab

---
https://ansm.sante.fr/tableau-acces-derogatoire/maralixibat
2024
false
false
false
France
French
drug information
insurance, health, reimbursement
maralixibat
Maralixibat Chloride
administration, oral
maralixibat chloride
alagille syndrome
pruritus
Cholestatic pruritus (disorder)

---
https://www.has-sante.fr/jcms/p_3423139/fr/spevigo-spesolimab-psoriasis-pustuleux-generalise-ppg
2024
false
false
false
France
Generalized pustular psoriasis
spesolimab
adult
treatment outcome
insurance, health, reimbursement
infusions, intravenous
evaluation of the transparency committee
psoriasis
spesolimab

---
https://medqual.fr/images/GP/ATB/2024-COTRIMOXAZOLE.pdf
2024
false
true
false
France
patient education handout
Trimethoprim-Sulfamethoxazole

---
https://ansm.sante.fr/tableau-acces-derogatoire/upstaza
2024
false
false
false
France
French
Eladocagene Exuparvovec
drug information
infant
Aromatic-L-Amino-Acid decarboxylases
Aromatic-L-Amino-Acid Decarboxylase
aromatic amino acid decarboxylase deficiency

---
https://ansm.sante.fr/tableau-acces-derogatoire/tecartus-0-4-2-x-108-cellules-dispersion-pour-perfusion
2024
false
false
false
France
French
brexucabtagene autoleucel
drug information
Refractory B Acute Lymphoblastic Leukemia
precursor cell lymphoblastic Leukemia-Lymphoma
brexucabtagene autoleucel
gene therapy

---
https://ansm.sante.fr/tableau-acces-derogatoire/ivosidenib
2024
false
false
false
France
French
administration, oral
summary of product characteristics
cholangiocarcinoma
guidelines for drug use
leukemia, myeloid, acute
glioma
myelodysplastic syndromes
antineoplastic agents
ivosidenib
ivosidenib
neoplasm metastasis
package leaflet

---
https://ansm.sante.fr/tableau-acces-derogatoire/ripretinib-50-mg-comprime
2024
false
false
false
France
French
administration, oral
ripretinib
ripretinib
drug information
gastrointestinal stromal tumors
Refractory Malignant Gastrointestinal Stromal Tumor
adult
antineoplastic agents

---
https://ansm.sante.fr/tableau-acces-derogatoire/sotrovimab-500-mg-solution-a-diluer-pour-perfusion-intraveineuse-xevudy
2024
false
false
false
France
French
infusions, intravenous
drug information
adult
adolescent
COVID-19
sotrovimab
sotrovimab

---
https://ansm.sante.fr/tableau-marr/dabigatran
2024
false
false
false
France
French
guidelines for drug use
risk management
Dabigatran
Dabigatran
dabigatran etexilate
administration, oral
antithrombins
antithrombins
continuity of patient care
hemorrhage
risk
adult
child

---
https://ansm.sante.fr/tableau-acces-derogatoire/keytruda-25-mg-ml-solution-a-diluer-pour-perfusion#
2024
false
false
false
France
French
drug information
triple negative breast neoplasms
pembrolizumab
pembrolizumab
summary of product characteristics
package leaflet
guidelines for drug use
adult
Early Stage Triple-Negative Breast Carcinoma
Locally Advanced Triple-Negative Breast Carcinoma
inflammatory breast neoplasms
Antineoplastic Agents, Immunological
endometrial neoplasms
clear cell renal cell carcinoma
renal cell carcinoma at increased risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions

---
https://ansm.sante.fr/tableau-acces-derogatoire/idefirix
2024
false
false
false
France
French
infusions, intravenous
imlifidase
Imlifidase
kidney transplantation
Anti-HLA hyperimmunization
drug information

---
https://ansm.sante.fr/tableau-acces-derogatoire/vutrisiran
2024
false
false
false
France
French
Vutrisiran
drug information
amyloidosis, hereditary, Transthyretin-Related
vutrisiran

---
https://ansm.sante.fr/dossiers-thematiques/prevenir-les-erreurs-avec-le-chlorure-de-potassium-injectable
2024
false
false
false
France
French
guidelines for drug use
medication errors
potassium chloride
infusions, intravenous
drug compounding
drug storage
drug prescriptions

---
https://ansm.sante.fr/actualites/nulojix-belatacept-pour-la-greffe-de-rein-recommandations-temporaires-pour-garantir-la-continuite-des-soins
2024
false
false
false
France
French
guidelines for drug use
Abatacept

---
https://ansm.sante.fr/tableau-marr/selexipag
2024
false
false
false
France
French
risk management
Uptravi
medication errors
selexipag
patients guideline
guidelines for drug use
Wrong dose
selexipag

---
https://www.has-sante.fr/jcms/p_3390379/fr/ciclograft-ciclosporine-greffe-de-cornee
2024
false
false
false
France
insurance, health, reimbursement
treatment outcome
graft rejection
drug therapy, combination
risk factors
guidelines for drug use
ophthalmic solutions
administration, ophthalmic
immunosuppressive agents
evaluation of the transparency committee
corneal transplantation
cyclosporine

---
https://ansm.sante.fr/tableau-acces-derogatoire/adcetris-50-mg-poudre-pour-solution-a-diluer-pour-perfusion
2024
false
false
false
France
French
continuity of patient care
guideline
hodgkin disease
child
adolescent
adult
antineoplastic combined chemotherapy protocols
brentuximab vedotin
Brentuximab Vedotin
infusions, intravenous

---
https://ansm.sante.fr/tableau-acces-derogatoire/berinert-500-ui-mg-poudre-et-solvant-pour-solution-injectable-perfusion
2024
false
false
false
France
French
complement C1 inhibitor protein
guidelines for drug use
continuity of patient care
salvage therapy
graft rejection
Humoral rejection
heart transplantation
kidney transplantation
lung transplantation
infusions, intravenous
complement C1 inhibitor protein
technical report

---
https://ansm.sante.fr/tableau-marr/tetradecyl-sulfate-de-sodium
2024
false
false
false
France
French
risk management
guidelines for drug use
continuity of patient care
sodium tetradecyl sulfate
sclerosing solutions
sodium tetradecyl sulfate
sodium tetradecyl sulfate
injections, intravenous
sclerotherapy

---
https://ansm.sante.fr/tableau-marr/teclistamab
2024
false
false
false
France
French
popular works
drug information
Teclistamab
risk management
teclistamab

---
https://ansm.sante.fr/tableau-marr/leflunomide
2024
false
false
false
France
French
risk management
patients guideline
guidelines for drug use
Leflunomide
leflunomide
administration, oral
immunosuppressive agents
continuity of patient care
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/cladribine
2024
false
false
false
France
French
risk management
cladribine
administration, oral
cladribine
immunosuppressive agents
cladribine
guidelines for drug use
patients guideline
Drug-Related side effects and adverse reactions
adult
multiple sclerosis, relapsing-remitting
continuity of patient care
hematologic tests

---
https://ansm.sante.fr/tableau-marr/panobinostat
2024
false
false
false
France
French
risk management
Panobinostat
panobinostat
administration, oral
medication errors
patients guideline
patient compliance

---
https://ansm.sante.fr/tableau-marr/tacrolimus
2024
false
false
false
France
French
risk management
tacrolimus
tacrolimus
administration, oral
guidelines for drug use
patient education handout
continuity of patient care
immunosuppressive agents

---
https://ansm.sante.fr/tableau-acces-derogatoire/kaftrio-75-mg-50-mg-100-mg-comprime-pellicule-kalydeco-150-mg-comprime-pellicule
2024
false
false
false
France
French
cystic fibrosis
guidelines for drug use
continuity of patient care
drug therapy, combination
administration, oral
ivacaftor, tezacaftor and elexacaftor
elexacaftor, ivacaftor, tezacaftor drug combination
ivacaftor
tezacaftor
elexacaftor
adult
adolescent
ivacaftor
trikafta
drug combinations
drug information

---
https://ansm.sante.fr/tableau-acces-derogatoire/ciclograft-20mg-ml-collyre-en-solution-en-recipient-unidose
2024
false
false
false
false
France
French
package leaflet
cyclosporine
administration, ophthalmic
guidelines for drug use
corneal transplantation
graft rejection
summary of product characteristics

---
https://ansm.sante.fr/tableau-atu-rtu/wegovy-solution-injectable-en-stylo-prerempli
2024
false
false
false
France
French
drug information
semaglutide
adult
obesity
weight loss
body mass index
risk factors
comorbidity
summary of product characteristics
package leaflet
guidelines for drug use
patients guideline
continuity of patient care
pregnancy
injections, subcutaneous

---
https://ansm.sante.fr/tableau-marr/ponesimod
2024
false
false
false
France
French
risk management
ponesimod
ponesimod
administration, oral
ponesimod
ponvory
guidelines for drug use
patients guideline
pregnancy
continuity of patient care
ponesimod
adult
multiple sclerosis, relapsing-remitting
drug monitoring
immunosuppressive agents
immunosuppressive agents
immunosuppressive agents

---
https://ansm.sante.fr/tableau-marr/nalmefene
2024
false
false
false
France
French
risk management
nalmefene
nalmefene
guidelines for drug use
patient education handout
administration, oral
patient compliance
patients guideline
alcohol drinking
continuity of patient care
nalmefene
alcoholism
adult
algorithms
Psychosocial Intervention

---
https://ansm.sante.fr/tableau-marr/capsaicine
2024
false
false
false
France
French
risk management
guidelines for drug use
capsaicin
administration, cutaneous
continuity of patient care
capsaicin

---
https://ansm.sante.fr/tableau-atu-rtu/primaquine-sanofi-15-mg-comprime-pellicule
2024
false
false
false
France
French
primaquine
summary of product characteristics
package leaflet
guidelines for drug use
primaquine
malaria, vivax
Ovale malaria (disorder)
recurrence
administration, oral
antimalarials
pneumonia, pneumocystis

---
https://ansm.sante.fr/tableau-marr/tolvaptan
2024
false
false
false
France
French
risk management
Tolvaptan
Tolvaptan
administration, oral
tolvaptan
polycystic kidney, autosomal dominant
continuity of patient care
liver diseases
pregnancy
guidelines for drug use
patients guideline
patient education handout

---
https://ansm.sante.fr/tableau-marr/olanzapine
2024
false
false
false
France
French
guidelines for drug use
patient education handout
Olanzapine
risk management
olanzapine
injections, intramuscular
Delayed-Action preparations
Olanzapine
metabolic diseases
continuity of patient care
drug compounding
injections, intramuscular
olanzapine pamoate
olanzapine pamoate
schizophrenia
antipsychotic agents
antipsychotic agents
medication errors
Post-injection delirium sedation syndrome (finding)

---
https://ansm.sante.fr/tableau-acces-derogatoire/selpercatinib-20-40-et-80mg-gelule
2024
false
false
false
France
French
selpercatinib
administration, oral
carcinoma, non-small-cell lung
advanced RET fusion-positive non-small cell lung cancer
Product containing only selpercatinib in oral dose form (medicinal product form)
drug information
selpercatinib
pyrazoles
pyridines

---
https://ansm.sante.fr/tableau-marr/ranibizumab
2024
false
false
false
France
French
risk management
Ranibizumab
Ranibizumab
patients guideline
intravitreal injections
patient education handout
package leaflet
ranibizumab

---
https://ansm.sante.fr/tableau-atu-rtu/abecma-260-500-x-106-cellules-dispersion-pour-perfusion
2024
false
false
false
France
French
guidelines for drug use
Idecabtagene Vicleucel
Idecabtagene Vicleucel
gene therapy
immunotherapy, adoptive
adult
multiple myeloma
recurrence
Refractory Multiple Myeloma
idecabtagene vicleucel
idecabtagene vicleucel
Recurrent Multiple Myeloma
genetic therapy

---
https://www.cochrane.org/fr/CD011851/VASC_des-rappels-par-sms-peuvent-ils-aider-les-personnes-souffrant-de-maladies-cardiaques-prendre
2024
false
false
false
France
United Kingdom
French
french abstract
review of literature
disease
cardiac drug, nos
caregivers
text messaging
persons
pharmaceutical preparations
heart disease, nos
homemaker services
heart diseases
regular
disease
persons

---
https://ansm.sante.fr/documents/reference/medicaments-biosimilaires
2024
false
false
false
France
French
drug information
biosimilar pharmaceuticals
directory

---
https://ansm.sante.fr/tableau-acces-derogatoire/yescarta-0-4-2-x-108-cellules-dispersion-pour-perfusion#
2024
false
false
false
France
French
axicabtagene ciloleucel
axicabtagene ciloleucel
biological products
Antineoplastic Agents, Immunological
Recurrent High Grade B-Cell Lymphoma
lymphoma, large B-Cell, diffuse
adult
Refractory High Grade B-Cell Lymphoma
drug information
immunotherapy, adoptive
antigens, CD19

---
https://ansm.sante.fr/tableau-marr/insuline-glargine
2024
false
false
false
France
French
Insulin Glargine
medication errors
risk management
insulin glargine
guidelines for drug use
patients guideline

---
https://ansm.sante.fr/tableau-marr/lenalidomide
2024
false
false
false
France
French
risk management
pregnancy
contraception
lenalidomide
multiple myeloma
lymphoma, mantle-cell
teratogens
continuity of patient care
drug monitoring
clinical chemistry tests
myelodysplastic syndromes
guidelines for drug use
popular works
venous thromboembolism
Tumor Flare Reaction
neoplasms
Chemical and Drug Induced Liver Injury
angiogenesis inhibitors
angiogenesis inhibitors
thalidomide
thalidomide
thalidomide
Lenalidomide
Lenalidomide

---
https://ansm.sante.fr/tableau-marr/pomalidomide
2024
false
false
false
France
French
risk management
pregnancy
contraception
teratogens
abnormalities, drug-induced
multiple myeloma
pomalidomide
continuity of patient care
Drug-Related side effects and adverse reactions
risk factors
guidelines for drug use
thrombocytopenia
neutropenia
blood cell count
thromboembolism
Infections
patient education handout
pregnancy tests
forms
thalidomide
thalidomide

---
https://ansm.sante.fr/tableau-marr/thalidomide
2024
false
false
false
France
French
risk management
thalidomide
teratogens
abnormalities, drug-induced
pregnancy
thalidomide
guideline
forms
patient education handout
continuity of patient care
Neuropathy peripheral
thromboembolism
Drug-Related side effects and adverse reactions
pregnancy tests
contraception
package leaflet

---
https://ansm.sante.fr/informations-de-securite/etoposide-injectable-risque-accru-de-reactions-dhypersensibilite-lorsque-la-ligne-de-perfusion-est-equipee-dun-filtre-en-ligne
2024
false
false
false
France
French
pharmacovigilance note

---
https://iris.who.int/handle/10665/375750
2024
Switzerland
journal article
Implementation
Nicotine Lozenge
vaccination
Consultation
vaccination
September
vaccinia virus vaccine
group processes
Reunion
advisory committees
preventive immunization/medication
Meeting
Vaccine Research
vaccines
Vaccination
research

---
https://www.louvainmedical.be/fr/article/consommer-moins-de-medicaments-et-mieux-un-imperatif-educationnel-et-environnemental
2024
Belgium
journal article
Environment
Consumption
Pharmacologic Substance
pharmaceutical preparations
Improved
Better than Others
GDC Therapeutic Agent Terminology
Medication
Environmental
environment
economics
drug, nos

---
https://ansm.sante.fr/tableau-acces-derogatoire/itraconazole
2024
false
false
false
France
French
itraconazole
guidelines for drug use
administration, oral
tinea
child
microsporum
antifungal agents
itraconazole
continuity of patient care

---
https://ansm.sante.fr/actualites/interdiction-de-la-publicite-aupres-du-grand-public-pour-libuprofene-400-mg
2024
false
false
false
France
French
drug information
ibuprofen
Advertising

---
https://ansm.sante.fr/informations-de-securite/pseudoephedrine-risques-de-syndrome-dencephalopathie-posterieure-reversible-pres-et-de-syndrome-de-vasoconstriction-cerebrale-reversible-rcvs
2024
false
false
false
France
French
pharmacovigilance note
pseudoephedrine
Posterior reversible encephalopathy syndrome (disorder)
posterior leukoencephalopathy syndrome
Reversible cerebral vasoconstriction syndrome (disorder)
cerebrovascular disorders
pseudoephedrine
administration, oral
nasal decongestants
pseudoephedrine, combinations

---
https://ansm.sante.fr/actualites/avis-de-lansm-du-19-12-2023-sur-le-medicament-casgevy-le-cadre-dune-demande-daap
2024
false
false
false
France
French
drug information
exagamglogene autotemcel
Exagamglogene Autotemcel
Transfusion Dependent Beta Thalassemia

---
https://ansm.sante.fr/actualites/decision-du-13-02-2024-cadre-de-prescription-compassionnelle-de-tibsovo-ivosidenib-250mg-comprime-pellicule
https://ansm.sante.fr/tableau-acces-derogatoire/ivosidenib
2024
false
false
false
France
French
drug information
administration, oral
ivosidenib
adult
glioma
guidelines for drug use
continuity of patient care
Unresectable Low Grade Glioma
Refractory Low Grade Glioma
IDH1 Gene Mutation
ivosidenib

---
https://cps.ca/fr/documents/position/pharmacotherapie-genes-medicaments-psychoactifs
2024
Canada
practice guideline
genes
Adolescents
Gene
Offspring
adolescent
drug, nos
Nutritional Support
Pharmacotherapy
Medication
Pharmacologic Substance
adolescence
child, nos
child
Child
Mathematical Operator
drug therapy
pharmaceutical preparations
Teenager
Drug Therapy
GDC Therapeutic Agent Terminology
Adolescent

---
https://ansm.sante.fr/tableau-marr/aciclovir
2024
false
false
false
France
French
guideline
patients guideline
drug information
risk management
acyclovir
Accidental Drug Ingestion
Muco-adhesive Buccal Tablet Dosage Form

---
https://www.cbip.be/fr/articles/4263?folia=4259
2024
false
false
false
Belgium
French
journal article
drug information
glucocorticoids
administration, oral
Long-term current use of drug therapy (situation)

---
https://ansm.sante.fr/tableau-marr/methotrexate-per-os
2024
false
false
false
France
French
guidelines for drug use
risk management
methotrexate
administration, oral
patient education handout
medication errors

---
https://ansm.sante.fr/actualites/creation-dun-comite-scientifique-temporaire-pour-definir-les-conditions-de-la-substitution-des-medicaments-biosimilaires
https://ansm.sante.fr/actualites/decision-dg-ndeg-2024-97-creation-dun-creation-dun-comite-scientifique-temporaire-conditions-de-mise-en-oeuvre-de-la-substitution-des-medicaments-biologiques-similaires-a-lansm
2024
false
false
false
France
French
biosimilar pharmaceuticals
drug information
drug substitution

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-fevrier-2024-5-8-fevrier
2024
false
false
false
France
French
pharmacovigilance note
nirmatrelvir and ritonavir drug combination
nirmatrelvir and ritonavir drug combination
immunosuppressive agents
drug therapy, combination
drug interactions

---
https://www.has-sante.fr/jcms/p_3495284/fr/tak-755-apadamtase-alfa-purpura-thrombotique-thrombocytopenique-congenital-pttc
2024
false
false
false
France
enzyme replacement therapy
congenital thrombotic thrombocytopenic purpura
adolescent
adult
enzymes
evaluation of the transparency committee
purpura, thrombotic thrombocytopenic
Apadamtase Alfa

---
https://ansm.sante.fr/tableau-acces-derogatoire/casgevy
2024
false
false
false
France
French
biological products
exagamglogene autotemcel
Exagamglogene Autotemcel
summary of product characteristics
package leaflet
guidelines for drug use
risk management
beta-Thalassemia
Transfusion Dependent Beta Thalassemia
adolescent
adult
Cell positive for CD34 antigen (cell)
infusions, intravenous

---
https://ansm.sante.fr/tableau-marr/adalimumab
2024
false
false
false
France
French
Adalimumab
risk management
continuity of patient care
drug information
adult
child
patient education handout

---
https://medqual.fr/images/2024-COTRIMOXAZOLE.pdf
2024
France
patient education handout
drug information
trimethoprim
sulfamethoxazole
Trimethoprim
co-trimazole
Sulfamethoxazole

---
https://ansm.sante.fr/actualites/cannabis-medical-point-detape-sur-la-derniere-annee-de-lexperimentation-et-larrivee-de-medicaments-a-base-de-cannabis
2024
false
false
false
France
French
drug information
medical marijuana
Medical cannabis therapy

---
https://ansm.sante.fr/tableau-marr/fentanyl-6
2024
false
false
false
France
French
fentanyl
Fentanyl Citrate
risk management
administration, sublingual
guidelines for drug use
fentanyl
patients guideline
adult
breakthrough pain
drug prescriptions
narcotics
Cancer Pain

---
https://www.has-sante.fr/jcms/p_3495394/fr/takhzyro-lanadelumab-angioedeme-hereditaire
2024
false
false
false
France
French
insurance, health, reimbursement
lanadelumab
evaluation of the transparency committee
child
angioedemas, hereditary
Hereditary angioedema attack
lanadelumab
treatment outcome
guidelines for drug use
Product containing precisely lanadelumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug)

---
https://ansm.sante.fr/tableau-acces-derogatoire/tak-755
2024
false
false
false
France
French
Apadamtase Alfa
congenital thrombotic thrombocytopenic purpura
enzyme replacement therapy
summary of product characteristics
package leaflet
guidelines for drug use
ADAMTS13 Protein
purpura, thrombotic thrombocytopenic
child
adolescent
adult

---
https://sante.gouv.fr/IMG/pdf/feuille-de-route-medicaments-fevrier-2024.pdf
https://sante.gouv.fr/actualites/presse/communiques-de-presse/article/penuries-de-medicaments-la-ministre-du-travail-de-la-sante-et-des-solidarites
2024
France
technical report
Nutritional Supplement Drink
insurance, pharmaceutical services
industry
GDC Therapeutic Agent Terminology
insurance coverage
Date Available
Availability
drug insurance
drug, nos
drug industry
Long-Term
Pharmacologic Substance

---
https://www.cochrane.org/fr/CD013474/HAEMATOL_le-traitement-dentretien-apres-un-traitement-anterieur-est-il-plus-efficace-que-lobservation-ou-le
2024
United Kingdom
review of literature
french abstract
adulthood
Legal Adult
NCI CTEP SDC Chronic Lymphoid Leukemia Sub-Category Terminology
What Month is it
Observation
Illinois
Treatment Compliance
leukemia, lymphoid
Interleukin
leukaemia
Observation Study Epoch
adult
interviews as topic
Until Effective
chronic lymphocytic leukemia
leukemia, lymphocytic, chronic, B-Cell
Chronic Lymphocytic Leukemia
placebos
Prior Therapy
Maintenance Therapy
patient compliance
interview
Israel
Post-Therapy

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1368
2024
France
public health guidelines
Ventilation
Neither Agree or Disagree
administration, topical
Theophylline
Localized Disease
hygiene
Location of Oral Residue Following Swallowing
attentiveness
Location of Pharyngeal Residue Following Swallowing
risk
Relative Value
judgment
Local-Regional
Anatomic Site
ventilation
Usage
epidemics
ventilation, nos
Locally
with cleaniless
Epidemic Disorder
Usually Need Help from Another Person for Hygiene

---
https://www.has-sante.fr/jcms/p_3492882/fr/alvesco-ciclesonide-asthme
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
glucocorticoids
administration, inhalation
ciclesonide
evaluation of the transparency committee
asthma
ciclesonide

---
https://www.has-sante.fr/jcms/p_3497035/fr/iopamiron-iopamidol-produit-de-contraste-iode
2024
false
false
false
France
iopamidol
evaluation of the transparency committee
Iopamidol
iodine, nos
iopamidol
contrast media
iodine

---
https://www.has-sante.fr/jcms/p_3497017/fr/omnipaque-iohexol-produit-de-contraste-iode
2024
false
false
false
France
evaluation of the transparency committee
iodine
omnipaque
contrast media
iohexol

---
https://www.has-sante.fr/jcms/p_3497026/fr/mircera-methoxy-polyethylene-glycol-epoetine-beta-anemie-symptomatique-associee-a-l-insuffisance-renale-chronique-chez-les-enfants-ages-de-3-mois-a-moins-de-18-ans
2024
false
false
false
France
infant
adolescent
treatment outcome
insurance, health, reimbursement
hematinics
methoxy polyethylene glycol-epoetin beta
Anemia of chronic renal failure (disorder)
evaluation of the transparency committee
continuous erythropoietin receptor activator
polyethylene glycols
anemia
erythropoietin
methoxy polyethylene glycol-epoetin beta
renal insufficiency, chronic
child

---
https://www.cbip.be/fr/articles/4264?folia=4259
2024
false
false
false
Belgium
French
journal article
drug information

---
https://ansm.sante.fr/actualites/difficultes-dapprovisionnement-en-rythmodan-250-mg-lp-ce-medicament-doit-etre-remplace-par-rythmodan-100-mg
2024
false
false
false
France
French
guideline
drug information
disopyramide
Disopyramide Phosphate
administration, oral
anti-arrhythmia agents
patient education handout

---
https://ansm.sante.fr/actualites/difficultes-dapprovisionnement-en-methylphenidate-lansm-publie-des-recommandations-pour-les-pharmaciens
2024
false
false
false
France
French
drug information
guideline
methylphenidate
methylphenidate
patient education handout
administration, oral

---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/rythmodan-250-mg-a-liberation-prolongee-comprime-enrobe-disopyramide-phosphate-de
2024
false
false
false
France
French
disopyramide
administration, oral
drug information

---
https://www.has-sante.fr/jcms/p_3497065/fr/visipaque-iodixanol-produit-de-contraste-iode
2024
false
false
false
France
iodixanol
-
-
evaluation of the transparency committee
iodine
iodixanol
contrast media

---
https://www.has-sante.fr/jcms/p_3467830/fr/sam-de-la-cnam-sur-le-tramadol-par-voie-orale-rappeler-la-duree-maximale-de-prescription
2024
France
scientific and technical information
indexing
duration
Drug Delivery System
reminder systems
Oral Route of Administration
prescription, nos
Device System
medical order entry systems
macrophage activation syndrome
Doxorubicin/Semustine/Streptozocin Regimen
meconium aspiration syndrome
Concomitant Agent
Callback
tramadol
Prescription
Abstracting and Indexing
Tramadol Measurement
drug, nos
Reference
Reminder
decision support techniques
Genetic Reference Sequence
administration, oral
Maximum
Medicinal Product
operations research
Tramadol
mosaic variegated aneuploidy syndrome
Drug Delivery System Category
Sequence Alignment Map
pharmaceutical preparations
Decision Aid
Borg Category-Ratio 10 Perceived Exertion Score 10

---
https://www.has-sante.fr/jcms/p_3496824/fr/redonne
2024
France
health technology assessment
Therapeutic
SHOX Gene
Treatment
adulthood
Extraction
therapeutic uses
Therapeutic Procedure
Legal Adult
shoes
Prolonged Release Mechanism of Action
long
therapeutics
adult
Usage
Screening Observation Carried Forward Imputation Technique

---
https://www.cbip.be/fr/articles/4276?folia=4275
2024
false
false
false
Belgium
French
drug information
journal article

---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/folinate-de-calcium-ebewe-10-mg-ml-solution-injectable-pour-perfusion-folinate-de-calcium
2024
false
false
false
France
French
drug information
Leucovorin, Calcium (1:1) Salt
injections, intramuscular
infusions, intravenous
calcium folinate

---
http://beh.santepubliquefrance.fr/beh/2024/5/2024_5_1.html
2024
France
journal article
Convenient
france
French Language
Program
french
Screening for Colorectal Cancer
organization
cancer screening
Schedule
malignant neoplasm colon/rectum
screening for cancer
early detection of cancer
French Catheter Gauge
Organization
Participation
Respect
Scheduled
Colorectal Cancer
Version
appraiser
colorectal neoplasms
mass screening
Estimate
Statistical Estimation

---
https://www.has-sante.fr/jcms/p_3498146/fr/myozyme-alglucosidase-alfa-maladie-de-pompe-deficit-en-glucosidase-acide
2024
false
false
false
France
GAA protein, human
adult
adolescent
child
treatment outcome
insurance, health, reimbursement
enzyme replacement therapy
infusions, intravenous
alglucosidase alfa
glycogen storage disease type II, infantile
adult glycogen storage disease type II
Glycogen storage disease type II late onset (disorder)
evaluation of the transparency committee
glycogen storage disease type ii
alglucosidase alfa

---
https://ansm.sante.fr/tableau-acces-derogatoire/momelotinib
2024
false
false
false
France
French
drug information
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide

---
https://ansm.sante.fr/tableau-acces-derogatoire/inspra-25-mg-comprime-pellicule
2024
false
false
false
France
French
Eplerenone
continuity of patient care
guidelines for drug use
adult
hyperaldosteronism
technical report

---
https://ansm.sante.fr/tableau-acces-derogatoire/omaveloxolone
2024
false
false
false
France
French
summary of product characteristics
package leaflet
insurance, health, reimbursement
Omaveloxolone
administration, oral
guidelines for drug use
adult
adolescent
friedreich ataxia

---
https://ansm.sante.fr/actualites/renforcer-linformation-des-professionnels-de-sante-pour-une-utilisation-securisee-du-chlorure-de-potassium-kcl-injectable
2024
false
false
false
France
French
guidelines for drug use
training
potassium chloride
patient safety
potassium chloride
Serious Adverse Drug Reaction
infusions, intravenous
medication errors

---
https://ansm.sante.fr/actualites/abrogation-de-certaines-autorisations-de-mise-sur-le-marche-de-generiques-de-tecfidera
2024
false
false
false
France
French
drug information
drugs, generic
Dimethyl Fumarate
legislation, pharmacy
europe
drug approval
dimethyl fumarate
legislation, drug

---
https://ansm.sante.fr/actualites/decision-du-22-12-2023-modification-au-repertoire-des-groupes-generiques-mentionne-a-larticle-r-5121-5-du-code-de-la-sante-publique
2024
false
false
false
France
French
directory
drugs, generic

---
https://ansm.sante.fr/tableau-acces-derogatoire/danicopan
2024
false
false
false
France
French
drug information
danicopan
administration, oral
drug therapy, combination
Extravascular hemolysis (finding)
adult
paroxysmal nocturnal hemoglobinuria
hemolysis
danicopan

---
https://ansm.sante.fr/actualites/plan-hivernal-point-de-situation-sur-lapprovisionnement-de-certains-medicaments-majeurs-de-lhiver
2024
false
false
false
France
French
drug information
pharmaceutical preparations
france
amoxicillin
amoxicillin-potassium clavulanate combination
anti-bacterial agents

---
https://pharmainfo.be/
2024
false
false
false
Belgium
French
establishment, institution, organization
popular works
pharmaceutical preparations
belgium

---
https://www.has-sante.fr/jcms/p_3483264/fr/fluenz-tetra-vaccin-grippal-quadrivalent-vivant-attenue-nasal-vaccin-antigrippal
2024
false
false
false
France
evaluation of the transparency committee
Trivalent Live-Attenuated Influenza Vaccine
preventive immunization/medication
Nasal Route of Administration
Trial Element Duration
Influenza Vaccine
influenza virus vaccine
vaccines, attenuated
Quadrivalent Influenza Vaccine
Nasal Dosage Form
vaccination
nose, nos
influenza vaccines
Tea Leaf
Ezatiostat Hydrochloride
attenuated by

---
https://www.has-sante.fr/jcms/p_3487172/fr/botox-toxine-botulinique-type-a-blepharospasme-spasme-hemifacial-torticolis-spasmodique
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
botulinum toxin
neuromuscular agents
evaluation of the transparency committee
hemifacial spasm
botulinum toxins, type A
blepharospasm
torticollis
Spasmodic Torticollis

---
https://www.has-sante.fr/jcms/p_3481441/fr/ultibro-breezhaler-indacaterol/bromure-de-glycopyrronium-bronchopneumopathie-chronique-obstructive-bpco
2024
false
false
false
France
indacaterol
insurance, health, reimbursement
treatment outcome
drug combinations
indacaterol-glycopyrronium combination
adult
administration, inhalation
evaluation of the transparency committee
Glycopyrronium
pulmonary disease, chronic obstructive

---
https://www.has-sante.fr/jcms/p_3478096/fr/kalydeco-ivacaftor-mucoviscidose
2024
false
false
false
France
infant
child
evaluation of the transparency committee
ivacaftor
cystic fibrosis
ivacaftor
Ivacaftor
Cystic Fibrosis
cystic fibrosis
kalydeco
ivacaftor

---
https://www.anses.fr/fr/content/avis-2019-sa-0155
2024
false
false
false
France
French
scientific and technical information
plant extracts
plant preparations
dietary supplements
guidelines as topic

---
https://ansm.sante.fr/tableau-marr/inhibiteur-de-la-c1-esterase-humaine
2024
false
false
false
France
French
risk management
guidelines for drug use
continuity of patient care
Human C1-Esterase Inhibitor
patients guideline

---
https://ansm.sante.fr/actualites/en-cas-de-rhume-evitez-les-medicaments-vasoconstricteurs-par-voie-orale
2024
false
false
false
France
French
common cold
administration, oral
nasal decongestants
pseudoephedrine
pharmacovigilance note
patients guideline
nasopharyngitis
pseudoephedrine, combinations
myocardial infarction
stroke
Posterior reversible encephalopathy syndrome (disorder)
Reversible cerebral vasoconstriction syndrome (disorder)

---
https://ansm.sante.fr/tableau-marr/pirfenidone
2024
false
false
false
France
French
guidelines for drug use
risk management
pirfenidone
pirfenidone
administration, oral
patient education handout
photosensitization
Drug-induced photosensitivity (disorder)
pirfenidone
Chemical and Drug Induced Liver Injury
continuity of patient care
liver function tests
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/actualites/tensions-dapprovisionnement-en-corgard-80-mg-nadolol-ce-medicament-doit-etre-reserve-a-certains-patients-atteints-de-troubles-du-rythme-dorigine-genetique
2024
false
false
false
France
French
nadolol
drug information
guideline
patient education handout
Genetic cardiac rhythm disease
arrhythmias, cardiac
nadolol
arrhythmias, cardiac

---
https://ansm.sante.fr/tableau-marr/eculizumab-2
2024
false
false
false
France
French
risk management
eculizumab
eculizumab
eculizumab
guidelines for drug use
patient education handout
patients guideline
antibiotic prophylaxis
infusions, intravenous
Infections
sepsis
Drug-Related side effects and adverse reactions
meningococcal infections
vaccination
meningococcal vaccines

---
https://ansm.sante.fr/actualites/point-de-situation-des-approvisionnements-en-auto-injecteurs-dadrenaline
2024
false
false
false
France
French
drug information
epinephrine
france
Epinephrine autoinjector (physical object)

---
https://ansm.sante.fr/tableau-acces-derogatoire/bylvay
2024
false
false
false
France
French
insurance, health, reimbursement
odevixibat
odevixibat
summary of product characteristics
package leaflet
guidelines for drug use
infant
child
pruritus
cholestatic pruritus in Alagille syndrome
alagille syndrome

---
https://ansm.sante.fr/tableau-acces-derogatoire/rybrevant
2024
false
false
false
France
French
summary of product characteristics
amivantamab-vmjw
Antineoplastic Agents, Immunological
amivantamab
advanced non-small cell lung cancer with activating epidermal growth factor receptor exon 20 insertion mutations
carcinoma, non-small-cell lung
guidelines for drug use
package leaflet

---
https://ansm.sante.fr/tableau-marr/etanercept-1
2024
false
false
false
France
French
risk management
Etanercept
patients guideline
drug information
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/inotersen
2024
false
false
false
France
French
risk management
Inotersen
inotersen
Drug-Related side effects and adverse reactions
patients guideline
drug information
eye diseases
glomerulonephritis
thrombocytopenia
oligonucleotides
oligodeoxyribonucleotides, antisense

---
https://www.has-sante.fr/jcms/p_3498464/fr/freedom60
2024
France
health technology assessment
Drug Delivery System Category
Active Control
home infusion therapy
domicile
Infusion Method of Administration
Drug Delivery System
Infusion Procedure
perfusion
perfusion, nos
Chemotherapeutic Perfusion
Active State
Mechanism
Pet is as Active as it Has Been
Perfusion
mechanics
Device System
Active License

---
https://www.has-sante.fr/jcms/p_3499781/fr/ferinject-carboxymaltose-ferrique-carence-martiale
2024
false
false
false
France
insurance, health, reimbursement
treatment outcome
iron, parenteral preparations
injections, intravenous
infusions, intravenous
ferric carboxymaltose
ferric compounds
Iron Deficiencies
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3500260/fr/livmarli-maralixibat-syndrome-d-alagille
2024
false
false
false
France
Cholestatic pruritus (disorder)
treatment outcome
insurance, health, reimbursement
infant
child
administration, oral
pharmaceutical solutions
maralixibat chloride
Maralixibat Chloride
cholestatic pruritus in Alagille syndrome
evaluation of the transparency committee
alagille syndrome
maralixibat

---
https://www.has-sante.fr/jcms/p_3500210/fr/bylvay-odevixibat-prurit-cholestatique-associe-au-syndrome-d-alagille
2024
false
false
false
France
cholestatic pruritus in Alagille syndrome
Cholestatic pruritus (disorder)
treatment outcome
insurance, health, reimbursement
child
infant
administration, oral
odevixibat
evaluation of the transparency committee
odevixibat
alagille syndrome

---
https://www.has-sante.fr/jcms/p_3498452/fr/freedomedge
2024
France
health technology assessment
Mechanism
domicile
Infusion Method of Administration
Infusion Procedure
Chemotherapeutic Perfusion
Active State
perfusion
Active License
Drug Delivery System
perfusion, nos
Device System
Active Control
mechanics
Drug Delivery System Category
home infusion therapy
Perfusion
Pet is as Active as it Has Been

---
https://www.has-sante.fr/jcms/p_3500390/fr/lepticur-chlorhydrate-de-tropatepine-syndrome-parkinsonien-induit-par-les-neuroleptiques
2024
false
false
false
France
Tropatepine hydrochloride (substance)
Parkinsonism caused by neuroleptic drug (disorder)
treatment outcome
insurance, health, reimbursement
tropatepine
administration, oral
tablets
-
evaluation of the transparency committee
parkinson disease, secondary
tropatepine
antipsychotic agents

---
https://cms.cmq.org/files/documents/Fiches/fiche-ordon-ind-redaction.pdf
2024
Canada
scientific and technical information
Recollect
Best Practice
Montreal Cognitive Assessment Abstraction Test
best practices
Pharmacologic Substance
prescription drug, nos
nonprescription drugs
Medication
GDC Therapeutic Agent Terminology
Booster
drug recalls
Reminder
Callback
prescription drugs
writing

---
https://www.cbip.be/fr/articles/4277?folia=4275
2024
false
false
false
Belgium
French
journal article
drug information
pulmonary disease, chronic obstructive
administration, inhalation
Chronic obstructive pulmonary disease exacerbation
comparative effectiveness research
glucocorticoids
adrenergic beta-2 receptor agonists
Long-Acting beta2-adrenergic receptor Agonist
long-acting anticholinergic
cholinergic antagonists
bronchodilator agents

---
https://ansm.sante.fr/tableau-marr/tafamidis
2024
false
false
false
France
French
risk management
tafamidis
administration, oral
guidelines for drug use
tafamidis
adult
pregnancy
breast feeding
tafamidis
Cardiac Amyloidosis
amyloidosis, hereditary, Transthyretin-Related
amyloidosis, hereditary, Transthyretin-Related

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-mars-2024-4-7-mars
2024
false
false
false
France
French
drug information
mRNA Vaccines
COVID-19 Vaccines
Postmenopausal bleeding (finding)
pharmacovigilance

---
https://www.ema.europa.eu/en/medicines/human/EPAR/vueway
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
gadopiclenol
contrast media
gadopiclenol

---
https://www.ema.europa.eu/en/medicines/human/EPAR/elucirem
2024
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
contrast media
gadopiclenol
gadopiclenol
drug approval
europe
adult
child
adolescent
magnetic resonance imaging
risk management
product surveillance, postmarketing
blood-brain barrier
liver
kidney
pancreas
lung
prostate
breast
musculoskeletal system

---
https://www.ema.europa.eu/en/medicines/human/EPAR/rezzayo
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Rezafungin
Rezafungin
rezafungin acetate
orphan drug production
drug approval
europe
antifungal agents
antifungal agents
adult
candidiasis, invasive
infusions, intravenous
risk management
product surveillance, postmarketing
pregnancy
breast feeding
drug interactions
Rezafungin Acetate
Rezafungin Acetate
aged
beta-(1,3)-D-glucan synthase
drug evaluation, preclinical

---
https://www.ema.europa.eu/en/medicines/human/EPAR/yesafili
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
aflibercept
aflibercept
aflibercept
biosimilar pharmaceuticals

---
https://www.ema.europa.eu/en/medicines/human/EPAR/inaqovi
2024
false
false
false
Netherlands
French
English
decitabine and cedazuridine drug combination
decitabine and cedazuridine drug combination
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
cedazuridine
cedazuridine
drug approval
europe
antimetabolites, antineoplastic
antimetabolites, antineoplastic
adult
leukemia, myeloid, acute
administration, oral
risk management
product surveillance, postmarketing
pregnancy
breast feeding
drug interactions
decitabine, combinations
drug evaluation, preclinical
Product containing precisely cedazuridine 100 milligram and decitabine 35 milligram/1 each conventional release oral tablet (clinical drug)

---
https://www.ema.europa.eu/en/medicines/human/EPAR/orserdu
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
elacestrant
elacestrant
elacestrant
postmenopause
drug approval
europe
selective estrogen receptor modulators
selective estrogen receptor modulators
breast neoplasms
breast neoplasms, male
Locally Advanced Estrogen Receptor-Positive Breast Carcinoma
Metastatic Estrogen Receptor-Positive Breast Carcinoma
HER2-Negative Breast Carcinoma
administration, oral
risk management
product surveillance, postmarketing
drug interactions
Activating ESR1 Gene Mutation
breast neoplasms
estrogen receptor alpha
drug evaluation, preclinical

---
https://www.ema.europa.eu/en/medicines/human/EPAR/ebglyss
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
lebrikizumab
lebrikizumab
lebrikizumab
drug approval
europe
dermatitis, atopic
adult
child
adolescent
injections, subcutaneous
risk management
product surveillance, postmarketing
aged
pregnancy
breast feeding
drug interactions
Interleukin-13
drug evaluation, preclinical

---
https://www.ema.europa.eu/en/medicines/human/EPAR/herwenda
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Trastuzumab
Trastuzumab
trastuzumab
biosimilar pharmaceuticals

---
https://www.ema.europa.eu/en/medicines/human/EPAR/aqumeldi
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
enalapril maleate
enalapril maleate
enalapril

---
https://www.ema.europa.eu/en/medicines/human/EPAR/jaypirca
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
pirtobrutinib
pirtobrutinib
pirtobrutinib
orphan drug production

---
https://www.has-sante.fr/jcms/p_3500927/fr/adempas-riociguat-hypertension-arterielle-pulmonaire-htap
2024
France
evaluation of the transparency committee
riociguat
riociguat
Pulmonary Arterial Hypertension
Adempas
Pulmonary Arterial Hypertension
pulmonary hypertension, nos
hypertensive disease, nos
riociguat
Riociguat

---
https://www.ema.europa.eu/en/medicines/human/EPAR/degarelix-accord
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
degarelix
degarelix
degarelix
drugs, generic

---
https://www.ema.europa.eu/en/medicines/human/EPAR/tyruko
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Natalizumab
Natalizumab
natalizumab
biosimilar pharmaceuticals
multiple sclerosis
drug approval
europe
infusions, intravenous
immunologic factors
immunologic factors
drug interactions
pregnancy
breast feeding
continuity of patient care
drug evaluation, preclinical
adult
integrin alpha4beta1

---
https://www.ema.europa.eu/en/medicines/human/EPAR/tepkinly
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Epcoritamab
Epcoritamab
epcoritamab
orphan drug production
drug approval
europe
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
adult
lymphoma, large B-Cell, diffuse
Recurrent Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell Lymphoma
recurrence
injections, subcutaneous
risk management
product surveillance, postmarketing
pregnancy
breast feeding
drug interactions
aged
drug evaluation, preclinical

---
https://www.ema.europa.eu/en/medicines/human/EPAR/lyfnua
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Gefapixant
Gefapixant
gefapixant
drug approval
europe
purinergic P2X3 receptor antagonists
purinergic P2X3 receptor antagonists
purinergic P2X receptor antagonists
purinergic P2X receptor antagonists
Chronic Cough
adult
pregnancy
breast feeding
drug interactions
administration, oral
risk management
product surveillance, postmarketing
Refractory chronic cough (disorder)
Unexplained chronic cough (disorder)
aged
drug evaluation, preclinical

---
https://www.ema.europa.eu/en/medicines/human/EPAR/tevimbra
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
tislelizumab
tislelizumab
tislelizumab
orphan drug production
drug approval
europe
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
Esophageal Squamous Cell Carcinoma
neoplasm metastasis
Metastatic Esophageal Squamous Cell Carcinoma
Unresectable Esophageal Squamous Cell Carcinoma
Refractory Esophageal Squamous Cell Carcinoma
adult
infusions, intravenous
risk management
product surveillance, postmarketing
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical

---
https://www.ema.europa.eu/en/medicines/human/EPAR/enrylaze
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Asparaginase Erwinia chrysanthemi
Asparaginase Erwinia chrysanthemi
asparaginase

---
https://www.ema.europa.eu/en/medicines/human/EPAR/tyenne
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
tocilizumab
tocilizumab
tocilizumab
biosimilar pharmaceuticals

---
https://www.ema.europa.eu/en/medicines/human/EPAR/apretude
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
cabotegravir
cabotegravir
cabotegravir

---
https://www.ema.europa.eu/en/medicines/human/EPAR/talvey
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Talquetamab
Talquetamab
talquetamab
orphan drug production
multiple myeloma
Triple-Class Refractory Multiple Myeloma
Recurrent Multiple Myeloma
adult
drug approval
europe
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
injections, subcutaneous
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical

---
https://ansm.sante.fr/actualites/obesite-quel-profil-dutilisation-de-wegovy-en-france-pendant-son-acces-precoce
2024
false
false
false
France
French
drug information
obesity
Wegovy
semaglutide
Product containing only semaglutide in parenteral dose form (medicinal product form)
drug utilization review
Glucagon-Like Peptide-1 Receptor Agonists
pharmacoepidemiology
france
drug utilization

---
https://sante.gouv.fr/soins-et-maladies/medicaments/professionnels-de-sante/autorisation-de-mise-sur-le-marche/la-liste-en-sus/article/referentiel-des-indications-des-specialites-pharmaceutiques-inscrites-sur-la
2024
false
false
false
France
French
directory
Formularies, Hospital as Topic
pharmacy service, hospital
pharmaceutical preparations
Clinical Indication

---
https://www.has-sante.fr/jcms/p_3423859/fr/reflux-gastro-oesophagien-chez-l-enfant-de-moins-d-un-an-definitions-prise-en-charge-et-pertinence-des-traitements-pharmacologiques
2024
France
guideline
Improved
patient care management
pharmacology
Scientific Equipment
child, nos
Child Individual
pharmacologist
Definitive
Tool
child
Child Relation
Enhance
tool, nos
gastroesophageal reflux
Perflutren Lipid Microspheres
Professional Practice
professional practice
Pharmacotherapy
Gastroesophageal Reflux
gastroesophageal reflux
Adverse Event Definitely Related to Intervention
Charge
drug therapy

---
https://www.has-sante.fr/jcms/p_3498381/fr/reflux-du-nourrisson-un-medicament-est-il-necessaire
2024
France
patient education handout
As Needed
Medicinal Product
Israel
Illinois
drug, nos
Concomitant Agent
pharmaceutical preparations
reflux, nos
Ropinirole Hydrochloride
infant
GDC Reflux Treatment Terminology
Gastroesophageal Reflux
What Month is it
Handbook
Guide Device
Interleukin
GDC Reflux Treatment Type Terminology

---
https://www150.statcan.gc.ca/n1/pub/82-003-x/2024003/article/00001-fra.htm
2024
Canada
technical report
CDISC SDTM Submission Domain Abbreviation Terminology
residence characteristics
Story
health
Submission Domain
Correlation
Rating Myself
Respect
Individual
community
Use
Self-Assessment
Person
appraiser
Self Assessment
Self-Report
Estimate
Statistical Estimation
SANT Domain

---
https://www.has-sante.fr/jcms/p_3501976/fr/cosentyx-secukinumab-rhumatisme-psoriasique
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
secukinumab
injections, subcutaneous
Interleukin Inhibitors
adult
Interleukin-17
evaluation of the transparency committee
arthritis, psoriatic
secukinumab

---
https://ansm.sante.fr/informations-de-securite/paxlovid-nirmatrelvir-ritonavir-rappel-des-interactions-medicamenteuses-avec-certains-immunosuppresseurs-notamment-le-tacrolimus-pouvant-etre-fatales
2024
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
drug interactions
nirmatrelvir and ritonavir drug combination
nirmatrelvir
immunosuppressive agents
tacrolimus
COVID-19 Drug Treatment
adult
nirmatrelvir and ritonavir
tacrolimus

---
https://ansm.sante.fr/actualites/decision-dautorisation-dimportation-parallele-accordee-le-21-03-2024-triflucan-40-mg-ml-poudre-pour-suspension-buvable
2024
false
false
false
France
French
drug information
fluconazole
legislation, pharmacy
spain

---
https://ansm.sante.fr/actualites/decision-dautorisation-dimportation-parallele-accordee-le-21-03-2024-suvreza-20-mg-10-mg-comprime-pellicule
2024
false
false
false
France
French
drug information
legislation, pharmacy
drug combinations
Ezetimibe
Rosuvastatin Calcium
rosuvastatin and ezetimibe
spain

---
https://ansm.sante.fr/actualites/decision-du-21-03-2024-cadre-de-prescription-compassionnelle-de-tacrolimus-0-1-pommade
2024
false
false
false
France
French
drug information
tacrolimus
administration, cutaneous
ointments
legislation, pharmacy
adult
child
adolescent
vitiligo
tacrolimus

---
https://ansm.sante.fr/tableau-acces-derogatoire/tacrolimus#
2024
false
false
false
France
French
tacrolimus
drug information
administration, cutaneous
vitiligo

---
https://www.cochrane.org/fr/CD006712/FERTILREG_les-anesthesiques-locaux-sont-ils-efficaces-pour-le-traitement-de-la-douleur-lors-dune-interruption
2024
United Kingdom
review of literature
french abstract
Voluntary Report
What Month is it
pain management
withholding treatment
abortion, legal
pregnancy trimester, first
administration, topical
First Trimester
anesthetics, local
Tiaprofenic Acid
first trimester pregnancy
local anesthesia, nos
Treatment Interruption
local anesthetic, nos
Discontinue
Local Anesthesia Procedure
Pain Therapy
pain
abortion on demand
elective abortion

---
Ezetrol (ezetimibe) and the Risks of Drug-Induced Liver Injury and Severe Cutaneous Adverse Reactions
https://recalls-rappels.canada.ca/fr/avis-rappel/ezetrol-ezetimibe-et-risques-lesions-hepatiques-origine-medicamenteuse-et-reactions
2024
false
false
false
Canada
French
English
pharmacovigilance note
Ezetimibe
Chemical and Drug Induced Liver Injury
Drug-Induced Liver Disease
drug hypersensitivity syndrome
stevens-johnson syndrome
epidermal necrolysis, toxic
Drug-Induced stevens johnson syndrome
canada
administration, oral
ezetimibe
anticholesteremic agents

---
https://www.has-sante.fr/jcms/p_3503277/fr/evkeeza-evinacumab-hypercholesterolemie-homozygote-familiale
2024
false
false
false
France
child
treatment outcome
insurance, health, reimbursement
Homozygous Familial Hypercholesterolemia
antibodies, monoclonal
evinacumab
guidelines for drug use
package leaflet
summary of product characteristics
Product containing only evinacumab in parenteral dose form (medicinal product form)
infusions, intravenous
evaluation of the transparency committee
evkeeza
evinacumab

---
https://www.has-sante.fr/jcms/p_3503249/fr/elrexfio-elranatamab-myelome-multiple
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
antibodies, monoclonal
adult
multiple myeloma
package leaflet
summary of product characteristics
guidelines for drug use
recurrence
Triple-Class Refractory Multiple Myeloma
Recurrent Multiple Myeloma
Progressive Neoplastic Disease
evaluation of the transparency committee
Elranatamab

---
https://ordomedic.be/fr/avis/deontologie/dossier-medical/refus-par-un-m%C3%A9decin-g%C3%A9n%C3%A9raliste-dun-patient-dont-le-dossier-m%C3%A9dical-global-est-g%C3%A9r%C3%A9-par-un-autre-m%C3%A9decin-g%C3%A9n%C3%A9raliste-si-le-rendez-vous-est-pris-uniquement-pour-des-raisons-de-convenance-personnelle-du-patient.
2024
Belgium
scientific and technical information
Refuse
Other Gender
Other Route of Administration
patient appointments
Other Blood Form Product
Other Eye Color
Other Race
Patient File
Unknown if Has Sibling
Specify Another Form of Birth Control that was Used
Other License Status
general practitioners
Other Health Care Professional
other medical doctors
Other Medication Given for Kawasaki Disease
Other Molecular Analysis
Other Pathologic Findings
appointments and schedules
Medical Record
Anatomic Sites, Other
History of Other Non-Cardiac Surgery
thinking, nos
Reasoning
has patient
Other Tumor Site
Primary Care Provider
HPV-Other Type
Other Edition
prejudice
medical records
Performance Status Scale Timing Other
Other Exacerbating Factor to Chief Complaint
Other Histologic Grade
Other Medication Given for Rheumatic Fever
Propofol Infusion Syndrome
Other Frequency of Chief Complaint
Unique
Other HPV Typing Method
Other Cytogenetic Analysis Abnormality Type
Other Non-Neoplastic Finding
Trash
general practice
History of Other Medical Treatment
Other Establishment Activity
Other Presenting Finding of Congenital Heart Disease
Other Histologic Type

---
https://ansm.sante.fr/tableau-marr/elranatamab
2024
false
false
false
France
French
risk management
Elranatamab
drug information
patients guideline
Cytokine Release Syndrome
nervous system diseases

---
https://ansm.sante.fr/informations-de-securite/adagrasib-risque-potentiel-deffets-indesirables-cutanes-severes
2024
false
false
false
France
French
pharmacovigilance note
risk
adagrasib
stevens-johnson syndrome
epidermal necrolysis, toxic
adagrasib
antineoplastic agents
Adagrasib Regimen

---
https://ansm.sante.fr/tableau-marr/ranibizumab-2
2024
false
false
false
France
French
Ranibizumab
byooviz
drug information
patient education handout
risk management
Drug-Related side effects and adverse reactions
signs and symptoms
ranibizumab
intravitreal injections

---
https://www.has-sante.fr/jcms/p_3488284/fr/caspofungine-tillomed-caspofungine-antimycotique-a-usage-systemique
2024
false
false
false
France
drugs, generic
infusions, intravenous
caspofungin
evaluation of the transparency committee
Caspofungin
antifungal agents

---
https://www.has-sante.fr/jcms/p_3487904/fr/xolair-omalizumab-polypose-naso-sinusienne
2024
false
false
false
France
nasal polyps
Polyp of nasal cavity and/or nasal sinus (disorder)
evaluation of the transparency committee
xolair
Omalizumab
Polyposis
Omalizumab

---
https://www.has-sante.fr/jcms/p_3488174/fr/nplate-romiplostim-thrombopenie-immunologique-primaire-pti-refractaire-aux-autres-traitements
2024
false
false
false
France
Primary Immune Thrombocytopenia
evaluation of the transparency committee
nplate
principal
Romiplostim
Immunotherapy
romiplostim
Refractory
thrombocytopenia due to immune destruction, nos
Primary Refractory
romiplostim
idiopathic thrombocytopenic purpura, nos
Other Therapy
Immune
Immunology
thrombocytopenia
purpura, thrombocytopenic, idiopathic
immunology

---
https://esante.gouv.fr/produits-services/repertoire-ror
France
directory
Offer
Resource Guide
directories as topic
social support
socialism
Research Resource
Social
measles-mumps-rubella vaccine
health resources
Means

---
https://publications.msss.gouv.qc.ca/msss/document-003676/
2024
Canada
guidelines for drug use
Transference
Ambulatory Care Facility
Usage
Clinical Data
Countertransference
Transfer, Psychology
Healthcare Activity
Intervention for Congenital Heart Disease
Clinical Batch
clinical protocols
Healthcare
Clinical Lot
Transfer
nursing
Care
On Study
Clinical Study Protocol
How True Feel Carefree Right Now
Intervention
Transfer Ability
Stooping

---
https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-liees-au-travail/maladies-a-caractere-professionnel/documents/rapport-synthese/priorisation-des-couples-maladie-facteur-de-risque-pour-l-estimation-du-fardeau-environnemental-et-professionnel-de-la-maladie-en-france
2024
France
technical report
Health Care Professional Promotional Material
Risk Estimate
appraiser
Disease Steps Clinical Classification
france
tularemia
CHFR Gene
family characteristics
risk factors
tularemia, nos
Professional Occupation
environmental illness
risk factor
couples
risk assessment
Couple
Disease Free
Environmental Risk Factor
Disease Object
cost of illness
occupational diseases
hazardous substances
Coupler Device
Burden
No Evidence of Coronary Artery Disease

---
https://ansm.sante.fr/actualites/decision-dautorisation-dimportation-parallele-accordee-le-06-12-2023-depakine-chrono-500-mg-comprime-pellicule-secable-a-liberation-prolongee
2024
false
false
false
France
French
legislation, pharmacy
drug information

---
https://ansm.sante.fr/tableau-marr/susoctocog-alfa
2024
false
false
false
France
French
risk management
Susoctocog Alfa
medication errors
guidelines for drug use
drug dosage calculations
video recording

---
https://www.has-sante.fr/jcms/p_3490695/fr/casgevy-exagamglogene-autotemcel-thalassemie-dependante-des-transfusions-tdt
2024
false
false
false
France
biological products
insurance, health, reimbursement
treatment outcome
Transfusion Dependent Beta Thalassemia
beta-Thalassemia
exagamglogene autotemcel
adolescent
young adult
infusions, intravenous
adoptive transfer
evaluation of the transparency committee
Exagamglogene Autotemcel

---
https://ansm.sante.fr/actualites/nouvelles-donnees-en-faveur-dun-risque-accru-de-saignements-menstruels-abondants-apres-la-primovaccination-contre-le-covid-19
2024
false
false
false
France
French
pharmacovigilance note
COVID-19 Vaccines
vaccination
COVID-19
mRNA Vaccines
Administration of first dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)
technical report
menorrhagia
covid-19, RNA-based vaccine
risk
risk assessment

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-janvier-2024-8-11-janvier
2024
false
false
false
France
French
risk management
valproic acid
Male
Neurodevelopmental Disorders
Chimeric antigen receptor T-cell therapy
genetic therapy
Secondary Carcinoma
Chimeric Antigen Receptor Therapy
immunotherapy, adoptive
pharmacovigilance note

---
https://db.swisspeddose.ch/fr/
2024
Switzerland
database
drug information
base, nos
Source Data Not Available
Childhood-Onset Systemic Lupus Erythematosus
Pediatric
pediatrician
database
Database
Pediatricians
databases as topic
Pediatric
Clinical Trial Source Data
pediatrics

---
https://www.has-sante.fr/jcms/p_3490837/fr/esbriet-pirfenidone-fibrose-pulmonaire-idiopathique-fpi-severe
2024
false
false
false
France
evaluation of the transparency committee
Borg Category-Ratio 10 Perceived Exertion Score 5
Epidermal cGVHD Score 4
fibrosis of lung, nos
Severe Adverse Event
Pirfenidone
idiopathic pulmonary fibrosis
severe
esbriet
Severe Dysplasia
pirfenidone
unknown (origin)
Severe Hallucination
Idiopathic Pulmonary Fibrosis
Severe Extremity Pain
Intensity and Distress 5
pirfenidone

---
https://ansm.sante.fr/actualites/plan-hivernal-point-de-situation-sur-lapprovisionnement-des-medicaments-majeurs-de-lhiver
2024
false
false
false
France
French
france
drug information
pharmaceutical preparations
anti-bacterial agents
amoxicillin

---
https://ansm.sante.fr/tableau-marr/mecasermine
2024
false
false
false
France
French
risk management
mecasermin
mecasermin
mecasermin
Drug-Related side effects and adverse reactions
patient education handout
guidelines for drug use
mecasermin
hypoglycemia
injections, subcutaneous

---
https://www.cochrane.org/fr/CD007837/BACK_quels-types-dexercices-therapeutiques-sont-les-plus-appropries-pour-traiter-la-scoliose-chez-les
2024
false
United Kingdom
France
French
meta-analysis
exercise therapy
scoliosis
adolescent
treatment outcome
summary of product characteristics
french abstract

---
https://www.has-sante.fr/jcms/p_3505636/fr/rybrevant-amivantamab-cancer-bronchique
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
antineoplastic combined chemotherapy protocols
carboplatin
amivantamab
Antineoplastic Agents, Immunological
bispecific monoclonal antibodies
advanced non-small cell lung cancer with activating epidermal growth factor receptor exon 20 insertion mutations
carcinoma, non-small-cell lung
carcinoma, non-small-cell lung
Activating EGFR Exon 20 Mutation
EGFR Exon 20 Insertion Mutation
Pemetrexed
adult
package leaflet
summary of product characteristics
guidelines for drug use
infusions, intravenous
evaluation of the transparency committee
bronchial neoplasms
amivantamab-vmjw

---
https://www.has-sante.fr/jcms/p_3505761/fr/retsevmo-selpercatinib-cancer-bronchique-non-a-petites-cellules
2024
false
false
false
France
bronchial neoplasms
adult
treatment outcome
insurance, health, reimbursement
antineoplastic agents
administration, oral
selpercatinib
package leaflet
summary of product characteristics
guidelines for drug use
advanced RET fusion-positive non-small cell lung cancer
RET Fusion Positive
carcinoma, non-small-cell lung
Advanced Lung Non-Small Cell Carcinoma
evaluation of the transparency committee
selpercatinib
carcinoma, non-small-cell lung

---
https://www.has-sante.fr/jcms/p_3505740/fr/lojuxta-lomitapide-hypercholesterolemie-familiale-homozygote
2024
false
false
false
France
Lomitapide Mesylate
Homozygous Familial Hypercholesterolemia
child
adolescent
evaluation of the transparency committee
lomitapide
Lomitapide Mesylate
mesylates

---
https://www.reiso.org/articles/themes/vieillesse/12246-participation-active-pour-le-vieillissement-en-sante
2024
Switzerland
journal article
Password Aging
activator appliances
health
Participation
aging
Aging
aging
activir
Activation

---
https://www.cbip.be/fr/elderlymeds
2024
false
false
false
Belgium
French
Dutch
aged
pharmaceutical preparations
drug prescriptions
guidelines for drug use

---
https://ansm.sante.fr/actualites/avis-de-lansm-du-11-03-2024-sur-le-medicament-keytruda-dans-le-cadre-dune-demande-daap
2024
false
false
false
France
French
treatment outcome
pembrolizumab
Antineoplastic Agents, Immunological
drug information
Resectable Lung Non-Small Cell Carcinoma
carcinoma, non-small-cell lung
neoplasm recurrence, local
risk
pembrolizumab

---
https://ansm.sante.fr/tableau-marr/belatacept
2024
false
false
false
France
French
guidelines for drug use
risk management
BELATACEPT
immunosuppressive agents
infusions, intravenous
belatacept
patient education handout
Infusion-Related Reaction
infusions, intravenous

---
https://ansm.sante.fr/tableau-marr/sutimlimab
2024
false
false
false
France
French
risk management
sutimlimab
guidelines for drug use
sutimlimab
antibodies, monoclonal, humanized
infusions, intravenous
Infections
Infections
meningococcal vaccines
meningococcal infections
vaccination
serious infection
patient education handout

---
https://ansm.sante.fr/actualites/progestatifs-et-risque-de-meningiomes-intracraniens-le-bmj-publie-une-etude-epidemiologique-francaise
2024
false
false
false
France
French
pharmacovigilance note
epidemiologic studies
france
meningioma
meningioma
medroxyprogesterone acetate
risk assessment
Product containing only levonorgestrel in intrauterine dose form (medicinal product form)
levonorgestrel
injections, intramuscular
plastic iud with progestogen
administration, intravaginal
progestins
intrauterine devices
medroxyprogesterone

---
https://ansm.sante.fr/tableau-marr/glucagon
2024
false
false
false
France
French
guidelines for drug use
risk management
glucagon
glucagon
administration, intranasal
patient education handout

---
https://ansm.sante.fr/tableau-acces-derogatoire/blenrep
2024
false
false
false
France
French
infusions, intravenous
drug information
antibodies, monoclonal, humanized
belantamab mafodotin
Antineoplastic Agents, Immunological

---
https://ansm.sante.fr/informations-de-securite/en-cas-de-rhume-ne-pas-utiliser-de-medicaments-a-base-de-pseudoephedrine-vasoconstricteurs-par-voie-orale
2024
false
false
false
France
French
pseudoephedrine
administration, oral
pharmacovigilance note
nasal decongestants
common cold
risk factors
risk
pseudoephedrine
pseudoephedrine, combinations
guidelines

---
https://ansm.sante.fr/tableau-marr/ritlecitinib
2024
false
false
false
France
French
risk management
Ritlecitinib
Drug-Related side effects and adverse reactions
ritlecitinib
guidelines for drug use
patient education handout
administration, oral
Janus Kinase Inhibitors
Immunomodulating Agents

---
https://ansm.sante.fr/tableau-marr/dronedarone
2024
false
false
false
France
French
risk management
continuity of patient care
Dronedarone
Dronedarone
dronedarone
administration, oral
guidelines for drug use
patient education handout
atrial fibrillation
Persistent Atrial Fibrillation
Paroxysmal Atrial Fibrillation
anti-arrhythmia agents
anti-arrhythmia agents

---
https://ansm.sante.fr/tableau-acces-derogatoire/tigilanol-tiglate
2024
false
false
false
France
French
Tigilanol Tiglate
drug information
Intratumoral use

---
https://ansm.sante.fr/tableau-acces-derogatoire/flunatop
2024
false
false
false
France
French
administration, oral
summary of product characteristics
drug information
flunarizine

---
https://ansm.sante.fr/tableau-acces-derogatoire/a-cq-100
2024
false
false
false
France
French
summary of product characteristics
drug information
chloroquine diphosphate
administration, oral
malaria, vivax

---
https://ansm.sante.fr/tableau-acces-derogatoire/vorasidenib
2024
false
false
false
France
French
drug information
administration, oral
vorasidenib
glioma
antineoplastic agents

---
https://ansm.sante.fr/tableau-acces-derogatoire/fruzaqla
2024
false
false
false
France
French
administration, oral
fruquintinib
antineoplastic agents
fruquintinib
VEGFR Tyrosine Kinase Inhibitor
summary of product characteristics
drug information
colorectal neoplasms
neoplasm metastasis

---
https://ansm.sante.fr/tableau-acces-derogatoire/irenat
2024
false
false
false
France
French
administration, oral
pharmaceutical solutions
sodium perchlorate
summary of product characteristics
package leaflet
drug information
Iodine-Induced Hyperthyroidism
Hypothyroidism due to iodide organification defect (disorder)

---
https://www.ema.europa.eu/en/medicines/human/EPAR/elrexfio
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
europe
drug approval
Elranatamab
Elranatamab
multiple myeloma
recurrence
Progressive Neoplastic Disease
Triple-Class Refractory Multiple Myeloma
adult
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
Recurrent Multiple Myeloma
antibodies, monoclonal
antibodies, monoclonal
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical
injections, subcutaneous
bispecific monoclonal antibodies
bispecific monoclonal antibodies
Immune Effector Cell Associated Neurotoxicity Syndrome
Elranatamab
Cytokine Release Syndrome
continuity of patient care

---
https://www.ema.europa.eu/en/medicines/human/EPAR/zilbrysq
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
zilucoplan
zilucoplan
zilucoplan
adult
myasthenia gravis
myasthenia gravis, generalized
generalised myasthenia gravis with anti-acetylcholine receptor antibody
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical
Anti-acetylcholine receptor antibody positivity
myasthenia gravis
risk management
injections, subcutaneous
drug therapy, combination

---
https://ansm.sante.fr/actualites/tramadol-moins-de-comprimes-dans-les-boites-pour-un-meilleur-usage
2024
false
false
false
France
French
tramadol
drug information

---
https://www.ordre.pharmacien.fr/les-communications/focus-sur/les-autres-publications/la-securite-des-pharmaciens-d-officine-bilan-2023
2024
France
technical report
pharmacist
Safety Study
Balance Sheet
pharmacists
safety
Safety
Checkup

---
https://medqual.fr/images/2024-CYCLINES.pdf
2024
France
drug information
popular works
Cyclin
cyclins

---
https://medqual.fr/images/GP/ATB/2024-_MACROLIDES.pdf
2024
France
drug information
popular works
Macrolide
macrolides

---
Nous contacter.
28/04/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.